Skip to main content
Log in

The use and interpretation of biomarkers of environmental genotoxicity in humans

  • Published:
Biotherapy

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Aidoo A, Lyn-Cook LE, Mittelstaedt RA, Heflich RH, Casciano DA. Induction of 6-thioguanine-resistant lymphocytes in Fischer 344 rats follow in vivo exposure to N-ethyl-N-nitrosourea and cyclophosphamide. Environ Mol Mutagen 1991; 17: 141–51.

    Google Scholar 

  2. Albertini RJ, Hayes RB. Somatic mutations in cancer epidemiology. Applications of Biomarkers to Cancer Epidemiology (eds P Toniolo, P Bofetta, D Shuker, N Rothman, B Hulka, N Pearce) IARC Scientific Publication No. 142 1996 (submitted).

  3. Albertini RJ, Nicklas JA, O'Neill JP. Future directions for evaluating human genetic and cancer risk from environmental exposures. Environ Health Perspect 1986; 104 (Suppl 3): 503–10.

    Google Scholar 

  4. Albertini RJ, Robison SH. Human Population Monitoring. In: Genetic Toxicology (eds AP Li, PH Heflich). Boca Raton: CRC Press 1991; 375–420.

    Google Scholar 

  5. Bonassi S, Abbondandolo A, Camurri L, Dal Pra L, De Ferrari M, Degrassi F, Forni A, Lamberti L, Lando C, Padovani P, Sbrana I, Vecchio D, Puntoni R. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet 1995; 79: 133–35.

    Google Scholar 

  6. Branda RF, O'Neill JP, Sullivan LM, Albertini RJ. Factors influencing mutation at the hprt locus in T-lymphocytes: Women treated for breast cancer. Cancer Res 1991; 51: 6603–7.

    Google Scholar 

  7. Cole J, Skopek TR. Intemational Commission for Protection against Environmental Mutagens and Carcinogens, Working Paper 3, Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo. Mutation Res 1994; 304: 33–106.

    Google Scholar 

  8. Committee on Biological Markers of the National Research Council Biological Markers in Environmental Health Research, Environmental Health Perspectives 1987; 74: 3–9.

    Google Scholar 

  9. Cosma GN and Garte SJ. Human gene inducibility: A marker of exposure and susceptibility to environmental toxicants. In: Molecular Environmental Biology (ed Garte SJ). Lewis Publishers, Boca Raton 1994; pp 225–46.

    Google Scholar 

  10. Eistman DA and Rupta DS. Fluorescence in situ hybridization. Application to Environmental Mutagenesis (eds DH Phillips, S Venitt). BIOS Scientific Publishers, Ltd., Oxford Press 1995; pp 315–39.

    Google Scholar 

  11. Finette BA, Poseno T, Albertini RJ. V(D)J recombinase mediated HPRT mutations in peripheral blood lymphocytes of normal children. Cancer Res 1996; 56: 1405–12.

    Google Scholar 

  12. Grdina DJ, Carnes BA, Grahn D, Sigdestad CP. Protection against late effects of radiation by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Res 1991; 51: 4125–30.

    Google Scholar 

  13. Grdina DJ, Ktaoka Y, Basic I, Perrin J. The radioprotector WR-2721 reduces neutron-induced mutations at the hypoxanthine-guanine phosphoribosyltransferase locus in mouse splenocytes when administered prior to or following irradiation. Carcino-genesis 1992; 13: 811–4.

    Google Scholar 

  14. Grant S, Bigbee WL. In vivo somatic mutation and segregation at the human glycophorin A (GPA) locus. Mutat Res 1993; 288: 163–72.

    Google Scholar 

  15. Hagmar L, Brogger A, Hansteen I-L, Heim S, Hogstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I, Reuterwall C, Salomaa S, Skerfving S, Sorsa M. Cancer risks in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 1994; 54: 2919–22.

    Google Scholar 

  16. Harris CC, Vahakangas K, Newman MJ, Trivers GE, Sharnsuddin A, Sinopoli N, Mann DL, Wright WE. Detection of benzo[a]pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. Proc Natl Acad Sci USA 1985; 82: 6672–6.

    Google Scholar 

  17. Haugen A, Becker G, Benstad C, Vahakangas K, Trivers GE, Newman MJ, Harris CC. Determination of polycyclic aromatic hydrocarbons in the urine, benzi[a]pyrene diol epoxide-DNA adducts in lymphocyte DNA, and antibodies to the adducts in sera from coke oven workers exposed to measured amounts of polycyclic aromatic hydrocarbons in the work atmosphere. Cancer Res 1986; 46: 4178–83.

    Google Scholar 

  18. Harnden DG. Inherited Susceptibility to Mutation. In: Environmental Mutagenesis (eds DH Phillips, S Venitt). BIOS Scientific Publishers, Ltd., Oxford 1995; pp 61–81.

    Google Scholar 

  19. Hulka BS, Margolin BH. Methodological issues in epidemiologic studies using biologic markers. Amer J Epidemiol 1992;135.

  20. Kleinerman RA, Littlefield LG, Tarone RE, Sayer AM, Cookfair DL, Wactawski-Wende J, Inskip PD, Block A, Ramesh KH, Boice JD Jr. Chromosome aberrations in lyrnphocytes from women irradiated for benign and malignant gynecological disease. Radiat Res 1994; 139: 40–6.

    Google Scholar 

  21. Phillips DH, Farmer PB. Protein and DNA adducts as biomarkers of exposure to environmental mutagens. In: Environmental Mutagens (eds DH Phillips, S Venitt). BIOS Scientific Publishers, Ltd., Oxford 1995; pp 367–95.

    Google Scholar 

  22. Rainville IR, Albertini RJ, O'Neill JP, Nicklas JA. Breakpoints and junctional regions of intragenic deletions in the hprt gene in human T-cells. Som Cell Molec Gen 1995; 21(5): 309–26.

    Google Scholar 

  23. Rothman N, Haas R, Hayes RB, Li G-L, Wiemels J, Campleman S, Quintana PJE, Xi L-J, Dosemeci M, Titenko-Holland N, Meyer KB, Lu W, Zhang LP, Bechtold W, Wang Y-Z, Kolachana P, Yin S-N, Blot W, Smith MT. Benzene induces gene-duplicating but not gene-inactivating mutations at the glycophorin A locus in exposed humans. Proc Nat Acad Sci USA 1995; 92: 4069–73.

    Google Scholar 

  24. Rothman N, Stewart WF, Rabkin CS, Schulte PA. The development, validation, and application of biomarkers for early biologic effects. Biomarkers and Occupational Health: Progress and Perspectives 1995; pp 109–15.

  25. Schatzkin A, Freedman LS, Schiffman MH, Dawsey SM. Validation of intermediate endpoints in cancer research. J Natl Cancer Inst 1990: 82: 1746–52.

    Google Scholar 

  26. Schulte PA. Use of biological markers in occupational health research and practice. J Toxicol and Environ Health 1993; 40: 359–66.

    Google Scholar 

  27. Smith G, Smith CAP, Wolf CR. Pharmacogenetic polymorphisms. In: Environmental Mutagenesis (eds DH Phillips, S Venitt). BIOS Scientific Publishers, Ltd., Oxford 1995: 83–106.

    Google Scholar 

  28. Swiger RR, Tucker JD. Fluorescence in situ hybridization: A brief review. Environ & Molec Mutagenesis 1996; 27: 245–54.

    Google Scholar 

  29. Tice RR. The single cell gel/Comet assay: A microgel electrophoretic technique for the detection of DNA damage and repair in individual cells. In: Environmental Mutagenesis (eds DH Phillips, S Venitt). BIOS Scientific Publishers, Ltd., Oxford 1995; 315–39.

    Google Scholar 

  30. Tucker JP, Eastmond DA, Littlefield LG. Cytogenetic end-points useful as biological dosimeters and predictors of risk in epidemiological studies. IARC Scientific Publication 1996 No. 142.

  31. Turner DR, Grist SA, Janatipour M, Morley AA. Mutations in human lymphocytes commonly involve gene duplication and resemble those seen in cancer cells. Proc Nat Acad Sci USA 1988 85: 3189–93.

    Google Scholar 

  32. Van Houten B, Albertini RJ. DNA damage and repair. In: Pathology of Environmental and Occupational Disease (ed Craighead JE)., Mosby 1995; pp 311–27.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Albertini, R.J. The use and interpretation of biomarkers of environmental genotoxicity in humans. Biotherapy 11, 155–167 (1998). https://doi.org/10.1023/A:1007990300835

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007990300835

Keywords

Navigation